Nahdi Medical Company (4164.SR)

SAR 120.8

(0.0%)

Operating Expenses Summary of Nahdi Medical Company

Nahdi Medical Company's latest annual operating expenses in 2023 was 2.47 Billion SAR , up 1.04% from previous year.
Nahdi Medical Company's latest quarterly operating expenses in 2024 Q3 was 675.2 Million SAR , up 1.48% from previous quarter.
Nahdi Medical Company reported a annual operating expenses of 2.53 Billion SAR in annual operating expenses 2022, up 4.3% from previous year.
Nahdi Medical Company reported a annual operating expenses of 2.43 Billion SAR in annual operating expenses 2021, up 26.55% from previous year.
Nahdi Medical Company reported a quarterly operating expenses of 675.2 Million SAR for 2024 Q3, up 1.48% from previous quarter.
Nahdi Medical Company reported a quarterly operating expenses of 665.3 Million SAR for 2024 Q2, up 6.79% from previous quarter.

Annual Operating Expenses Chart of Nahdi Medical Company (2023 - 2017)

Historical Annual Operating Expenses of Nahdi Medical Company (2023 - 2017)

Year	Operating Expenses	Operating Expenses Growth
2023	2.47 Billion SAR	1.04%
2022	2.53 Billion SAR	4.3%
2021	2.43 Billion SAR	26.55%
2020	1.92 Billion SAR	66.2%
2019	1.15 Billion SAR	-8.53%
2018	1.26 Billion SAR	1.15%
2017	1.24 Billion SAR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	623.01 Million SAR	-11.35%
2024 Q3	675.2 Million SAR	1.48%
2024 Q2	665.3 Million SAR	6.79%
2023 Q4	702.78 Million SAR	9.06%
2023 FY	2.56 Billion SAR	1.04%
2023 Q3	644.39 Million SAR	5.09%
2023 Q2	613.16 Million SAR	-1.69%
2023 Q1	623.67 Million SAR	-10.2%
2022 Q2	620.49 Million SAR	5.64%
2022 Q1	587.35 Million SAR	-15.22%
2022 Q3	632.55 Million SAR	1.94%
2022 FY	2.53 Billion SAR	4.3%
2022 Q4	694.55 Million SAR	9.8%
2021 FY	2.43 Billion SAR	26.55%
2021 Q4	692.77 Million SAR	18.72%
2021 Q3	583.52 Million SAR	-2.8%
2021 Q2	600.33 Million SAR	8.45%
2021 Q1	553.54 Million SAR	6.71%
2020 Q1	533.07 Million SAR	0.0%
2020 FY	1.92 Billion SAR	66.2%
2020 Q4	518.74 Million SAR	-21.75%
2020 Q3	662.96 Million SAR	3.71%
2020 Q2	639.23 Million SAR	19.91%
2019 FY	1.15 Billion SAR	-8.53%
2018 FY	1.26 Billion SAR	1.15%
2017 FY	1.24 Billion SAR	0.0%

Peer Operating Expenses Comparison of Nahdi Medical Company

Name	Operating Expenses	Operating Expenses Difference
Middle East Pharmaceutical Industries Co.	128.79 Million SAR	-1821.498%
Al-Dawaa Medical Services Company	1.59 Billion SAR	-54.868%
Al-Razi Medical Co.	12.26 Million SAR	-20083.581%
Almujtama Alraida Medical Co.	115.25 Million SAR	-2047.174%